Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

The Effect of Breastfeeding Support Provided Via Video-conferencing

15. juni 2021 opdateret af: Deniz Akyıldız, Kahramanmaras Sutcu Imam University

The Effect of Breastfeeding Support Provided Via Video-conferencing on Postpartum Anxiety, Breastfeeding Self-Efficacy and Neonatal Outcomes: A Randomized Controlled Trial

A randomized control trial was made to examine the effects of breastfeeding support given by the video-conferencing method in the early postpartum period on anxiety, breastfeeding self-efficiency, and newborn outcomes.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

78

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

  • Kalkun
    • Kahramanmaraş
      • Kahramanmaras, Kahramanmaraş, Kalkun, 4600
        • Rekruttering
        • Kahramanmaraş Sütçü İmam University
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

19 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

Infants;

  • Born between 37 and 42 weeks
  • Without severe congenital anomalies

Mothers;

  • A single live birth
  • Were 18 years of age or over
  • At least primary school graduate
  • Did not have a disease that prevents breastfeeding
  • Had internet access at home or on the phone
  • Could speak and understand the Turkish language.

Exclusion Criteria:

  • Situations that cause separation of mother and baby
  • Hospitalization of the baby in intensive care
  • Inability to answer 3 calls in a video call
  • They were determined as those who could not be reached during the home visit for the first and second follow

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Video-conferencing group
The mothers in the video-conferencing group were counseled via video-conferencing a total of six times (three times a week, at equal intervals) during the first 2 weeks after birth. Each interview was approximately 15-20 minutes. In video-conferencing sessions, the breastfeeding position, the mother's grasping the breast, the baby's latch-on, and sucking duration were observed. Mothers' questions were answered and solutions were offered for breastfeeding problems (sore nipple, engorgement, etc.).
Adfærdsmæssigt: Video-conferencing group
No intervention
Andre navne:
  • Kontrolgruppe
Ingen indgriben: Control group
The mothers in the control group were given usual care before discharge and no intervention was made after discharge.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The mean postpartum maternal anxiety level (mean ± SD)
Tidsramme: at 2 weeks and 4 weeks after delivery
The primary outcome of this study was the mean postpartum maternal anxiety level (mean ± SD) of the mothers at 2 weeks and 4 weeks after delivery. Maternal anxiety level was assessed using the Postpartum Specific Anxiety Scale. The scale comprises 51 items and 4 sub-dimensions. It means that those who score 73 and below on the scale have low postpartum anxiety levels, those who score between 74 and 100 have a medium level, and those who score 101 and above have a high level of anxiety.
at 2 weeks and 4 weeks after delivery
The mean breastfeeding self-efficacy level
Tidsramme: at 2 weeks and 4 weeks after delivery
The other main outcome of the study was the mean breastfeeding self-efficacy level (mean ± SD) measured with the Breastfeeding Self-Efficacy Scale Short Form. The scale is likert type and a total score between 14 and 70 is taken from the scale. The higher the score, the higher the breastfeeding self-efficacy.
at 2 weeks and 4 weeks after delivery

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Neonatal outcomes-Newborn weight (g)
Tidsramme: at 2 weeks and 4 weeks after delivery
Newborn weight (g) was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Hypoglycemia of the newborn
Tidsramme: at 2 weeks and 4 weeks after delivery
Hypoglycemia of the newborn was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery.
at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Need for phototherapy
Tidsramme: at 2 weeks and 4 weeks after delivery
The need for phototherapy was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Respiratory morbidity
Tidsramme: at 2 weeks and 4 weeks after delivery
Respiratory morbidity was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
at 2 weeks and 4 weeks after delivery
Neonatal outcomes-illness requiring hospitalization
Tidsramme: at 2 weeks and 4 weeks after delivery
Illness requiring hospitalization was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Food intake other than breast milk
Tidsramme: at 2 weeks and 4 weeks after delivery
Food intake other than breast milk was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Neonatal death
Tidsramme: at 2 weeks and 4 weeks after delivery
Neonatal death was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
at 2 weeks and 4 weeks after delivery

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Kahramanmaras Sutcu Imam University

Efterforskere

  • Ledende efterforsker: Betül Bay, Kahramanmaraş Sütçü İmam University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

25. august 2020

Primær færdiggørelse (Forventet)

30. september 2021

Studieafslutning (Forventet)

30. september 2021

Datoer for studieregistrering

Først indsendt

7. juni 2021

Først indsendt, der opfyldte QC-kriterier

15. juni 2021

Først opslået (Faktiske)

18. juni 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. juni 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

15. juni 2021

Sidst verificeret

1. juni 2021

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • Breastfeeding Support

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Video-conferencing group

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in South Africa

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner